共 50 条
- [41] Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (08): : 875 - 882
- [42] Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (01): : 11 - 33
- [43] Effect of Body Mass Index on Treatment of Vasomotor Symptoms Associated with Menopause MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1211 - 1212
- [44] Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms OBSTETRICS AND GYNECOLOGY, 2024, 143 (03): : 393 - 402
- [45] Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (03): : S14 - S19
- [48] Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause A Randomized Controlled Trial OBSTETRICS AND GYNECOLOGY, 2023, 141 (04): : 737 - 747
- [50] Prevalence and impact of vasomotor symptoms due to menopause among women in Brazil, Canada, Mexico, and Nordic Europe: a cross-sectional survey MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2023, 30 (12): : 1179 - 1189